Differential binding with ERα and ERβ of the phytoestrogen-rich plant Pueraria mirifica

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 2, 2010, Pages 195-200

  Boonchird, C ^a   Mahapanichkul, T ^a   Cherdshewasart, W ^b  

^a Mahidol University ^*  (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Estrogen receptor (ER ); Estrogen receptor (ER ); Isoflavonoid; Phytoestrogen; Pueraria mirifica; YES assay

Indexed keywords

ANTIESTROGEN; BETA GALACTOSIDASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIVER ENZYME; NUCLEAR RECEPTOR COACTIVATOR 2; PHYTOESTROGEN; PLANT EXTRACT; PUERARIA EXTRACT; PUERARIA MIRIFICA EXTRACT; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE; NCOA1 PROTEIN, HUMAN; NCOA2 PROTEIN, HUMAN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; GENE CASSETTE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; NONHUMAN; PLANT TUBER; PROTEIN BINDING; PROTEIN EXPRESSION; PUERARIA; PUERARIA MIRIFICA; RAT; REPORTER GENE; YEAST ESTROGEN SCREEN; ANIMAL; BIOASSAY; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

PUERARIA MIRIFICA; RATTUS;

ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOFLAVONES; LIVER; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR COACTIVATOR 2; PLANT EXTRACTS; PUERARIA; RATS;

EID: 76649106053     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009007500026     Document Type: Article

References (35)

1. Katzenellenbogen BS, Ferguson ER, Lan NC. Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action. Endocrinology 1977; 100: 1252-1259.
2. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 1966; 34: 215-225.
3. Wang C, Kurzer MS. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 1997; 28: 236-247.
4. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997; 62: 365-372.
5. Benson GK, Cowie AT, Hosking ZD. Mammogenic activity of miroestrol. J Endocrinol 1961; 21: 401-409.
6. Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol 2006; 107: 354-360.
7. Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the estrogenic activity of the wild Pueraria mirifica by vaginal cornification assay. J Reprod Dev 2007; 53: 385-393.
8. Cherdshewasart W, Sriwatcharakul S, Malaivijitnond S. Variance of estrogenic activity of the phytoestrogen-rich plant. Maturitas 2008; 61: 350-357.
9. Cherdshewasart W, Cheewasopit W, Picha P. The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. J Ethnopharmacol 2004; 93: 255-260.
10. Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica by MCF-7 proliferation assay. J Reprod Dev 2008; 54: 63-67.
11. Harmsen S, Meijerman I, Beijnen JH, Schellens JH. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat Rev 2007; 33: 369-380.
12. Bitter GA. Regulation of human estrogen receptor alphamediated gene transactivation in Saccharomyces cerevisiae by human coactivator and corepressor proteins. J Steroid Biochem Mol Biol 2007; 103: 189-195.
13. Cain JC. Miroestrol: an oestrogen from the plant Pueraria mirifica. Nature 1960; 188: 774-777.
14. Chansakaow S, Ishikawa T, Seki H, Sekine Y, Okada M, Chaichantipyuth C. Identification of deoxymiroestrol as the actual rejuvenating principle of "Kwao Keur", Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod 2000; 63: 173-175.
15. Cherdshewasart W, Subtang S, Dahlan W. Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal 2007; 43: 428-434.
16. Cherdshewasart W, Sriwatcharakul S. Major isoflavonoid contents of the 1-year-cultivated phytoestrogen-rich herb, Pueraria mirifica. Biosci Biotechnol Biochem 2007; 71: 2527-2533.
17. Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 2008; 15:530-535.
18. Manonai J, Chittacharoen A, Theppisai U, Theppisai H. Effect of Pueraria mirifica on vaginal health. Menopause 2007; 14: 919-924.
19. Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 2007; 56: 322-331.
20. Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S. Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas 2008; 59: 137-148.
21. Cherdshewasart W, Panriansaen R, Picha P. Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERα and ERβ. Maturitas 2007; 58: 174-181.
22. Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K. Effect of Pueraria mirifica on the sexual skin coloration of aged menopausal cynomolgus monkeys. J Reprod Dev 2006; 52: 537-542.
23. Jaroenporn S, Malaivijitnond S, Wattanasirmkit K, Watanabe G, Taya K, Cherdshewasart W. Assessment of fertility and reproductive toxicity in adult female mice after long-term exposure to Pueraria mirifica herb. J Reprod Dev 2007; 53: 995-1005.
24. Nishikawa J, Saito K, Goto J, Dakeyama F, Matsuo M, Nishihara T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol Appl Pharmacol 1999; 154: 76-83.
25. Morani A, Warner M, Gustafsson JA. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med 2008; 264: 128-142.
26. Lee HS, Miyauchi K, Nagata Y, Fukuda R, Sasagawa S, Endoh H, et al. Employment of the human estrogen receptor beta ligand-binding domain and co-activator SRC1 nuclear receptor-binding domain for the construction of a yeast two-hybrid detection system for endocrine disrupters. J Biochem 2002; 131: 399-405.
27. Kashemsanta MLC, Suvatabhandu K, Airy SHK. A new species of Pueraria (Leguminosae) from Thailand, yielding an oestrogenic principle. Kew Bull 1952; 7: 263-266.
28. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001; 24: 351-356.
29. Takatori S, Kitagawa Y, Oda H, Miwa G, Nishikawa J-I, Nishihara T, et al. Estrogenicity of metabolites of benzophenone derivatives examined by a yeast two-hybrid assay. J Health Sci 2003; 49: 91-98.
30. Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 2000; 174: 422-428.
31. Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003; 41: 631-636.
32. Lee YS, Park JS, Cho SD, Son JK, Cherdshewasart W, Kang KS. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica. J Vet Sci 2002; 3: 273-277.
33. Cherdshewasart W, Sriwatcharakul S. Metabolic activation promotes estrogenic activity of the phytoestrogen-rich plant. Maturitas 2008; 59: 128-136.
34. Kim G, Kang SC, Kim KC, Choung ES, Zee OP. Screening of estrogenic and antiestrogenic activities from medicinal plants. Environ Toxicol Pharm 2008; 25: 75-82.
35. Matsumura A, Ghosh A, Pope GS, Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2005; 94: 431-443.